EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Inhibition of the Renin-Angiotensin System Improves Response to Neoadjuvant Therapy in Patients With Liver Metastasis of Colorectal Cancers

Naita M Wirsik, Pia C Appel, Alexander Braun, Moritz J Strowitzki, Nikolai Schleussner, Henrik Nienhüser, Martin Schneider, Thomas Schmidt

Journal of Surgical Research · 2024

DOI: 10.1016/j.jss.2024.03.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Research, 2024. Verfasst von Naita M Wirsik und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University Hospital Heidelberg, Heidelberg, Germany; Department of General, Visceral, Cancer and Transplant Surgery, Universit…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Liver Neoplasms, Neoadjuvant Therapy, Renin-Angiotensin System. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Renin-angiotensin-aldosterone system inhibitors (RAAS-I) have been shown to prolong overall survival in patients with liver metastasized colorectal cancer in combination with antiangiogenic treatment. The effects of RAAS-I combined with neoadjuvant chemotherapy on colorectal cancer liver metastasis remain unexplored. We aimed to study the response of patients undergoing liver resection to RAAS-I in combination with neoadjuvant therapy to elucidate their potential benefits. METHODS: Between February 2005 and May 2012, 62 patients fulfilled the inclusion criteria for distant metastasis (cM1) and comparable computed tomography or magnetic resonance tomography scans in the Picture Archiving Communication System of our center before and after neoadjuvant chemotherapy. Follow-up data and clinicopathological characteristics were collected from a prospective database and retrospectively investigated. The chemotherapeutic response to liver metastasis was evaluated according to the Response Evaluation Criteria in Solid Tumors criteria 1.1. RESULTS: Comparing the average reduction of measured lesions, a significant response to chemotherapy was detected in the patients receiving RAAS-I (n = 24) compared to those who did not (n = 38) (P = 0.031). Interestingly, the effect was more distinctive when the size reduction was compared between high responses with more than 50% size reduction of all measured lesions (P = 0.011). In the subgroup analysis of patients receiving bevacizumab treatment, high responses to chemotherapy were observed only in the RAAS-I cohort (28.6% versus 0%, P = 0.022). CONCLUSIONS: For neoadjuvantly treated patients, concomitant antihypertensive treatment with RAAS-I showed a higher total size reduction of liver metastasis as a sign of treatment response, especially in combination with antiangiogenic treatment with bevacizumab.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsLiver NeoplasmsNeoadjuvant TherapyRenin-Angiotensin SystemHumansFemaleMaleMiddle AgedAgedRetrospective StudiesAngiotensin-Converting Enzyme InhibitorsAdultAntineoplastic Combined Chemotherapy ProtocolsHepatectomyTreatment OutcomeBevacizumabChemotherapy, AdjuvantAngiogenesis Inhibitors

Stichwörter der Autor:innen

BevacizumabChemotherapyColorectal cancerLiver metastasisRenin-angiotensin aldosterone inhibition

Substanzen

Angiotensin-Converting Enzyme InhibitorsBevacizumabAngiogenesis Inhibitors

Autor:innen und Institutionen

  • Department of Surgery, University Hospital Heidelberg, Heidelberg, Germany; Department of General, Visceral, Cancer and Transplant Surgery, University Hospital of Cologne, Cologne, Germany.
  • Department of Surgery, University Hospital Heidelberg, Heidelberg, Germany.
  • Department of Radiology, University Hospital Heidelberg, Heidelberg, Germany.
  • Department of Surgery, University Hospital Heidelberg, Heidelberg, Germany; Department of General, Visceral, Cancer and Transplant Surgery, University Hospital of Cologne, Cologne, Germany. Electronic address: Thomas.Sc…

Zitieren

APA

Wirsik, N. M., Appel, P. C., Braun, A., Strowitzki, M. J., Schleussner, N., Nienhüser, H., Schneider, M., & Schmidt, T. (2024). Inhibition of the Renin-Angiotensin System Improves Response to Neoadjuvant Therapy in Patients With Liver Metastasis of Colorectal Cancers. Journal of Surgical Research. https://doi.org/10.1016/j.jss.2024.03.013

Vancouver

Wirsik NM, Appel PC, Braun A, Strowitzki MJ, Schleussner N, Nienhüser H, et al. Inhibition of the Renin-Angiotensin System Improves Response to Neoadjuvant Therapy in Patients With Liver Metastasis of Colorectal Cancers. Journal of Surgical Research. 2024. doi:10.1016/j.jss.2024.03.013

BibTeX
@article{Wirsik2024,
  author = {Wirsik, Naita M and Appel, Pia C and Braun, Alexander and Strowitzki, Moritz J and Schleussner, Nikolai and Nienhüser, Henrik and Schneider, Martin and Schmidt, Thomas},
  title = {Inhibition of the Renin-Angiotensin System Improves Response to Neoadjuvant Therapy in Patients With Liver Metastasis of Colorectal Cancers},
  journal = {Journal of Surgical Research},
  year = {2024},
  doi = {10.1016/j.jss.2024.03.013}
}
Kostenlos starten →